Biotop-report 2014
Yüklə 0,7 Mb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Contact us: Phone: +49 (0)30 / 2125-4747 E-mail: wachsen@ibb.de www.ibb.de/wachsen
30 BioTOPics 47 | May 2014 BioTOP-Report 2014 ORGANOBALANCE GmbH Exploring and managing microbial biodiversity ORGANOBALANCE explores the potential of probiotic bacteria and yeasts for new prod- uct developments in food, feed, personal care, and for the pharmaceutical industry or the production of fine chemicals. From a large collection of microorganisms, specific strains are selected to e.g. inactivate patho- gens, produce new bioactives, neutralize malodorous or toxic substances and synthe- size high titers of valuable compounds. ORGANOBALANCE draws on natural resources, which are gathered in the compa- ny-owned collection of 8000+ microbial strains, mostly originating from foodstuffs. ORGANOBALANCE uses its OASSYS ® bioas- says for highly efficient screenings. The plat- form allows to quickly identify the most suit- able strains from the microbial collection for targeted applications. ORGANOBALANCE has a broad expertise in the field of yeast metabolic engineering. This includes designing and developing new pro- duction strains for industrial biotechnology applications. Specific strains of Saccharomy- ces cerevisiae, which carry engineered bio- synthesis pathways for the environmentally friendly production of carboxylic acids, ter- penoids, steroids and other lipid compounds are available. ORGANOBALANCE works in collaboration with partners and grants licenses for own product developments. Address
ORGANOBALANCE GmbH Gustav-Meyer-Allee 25 13355 Berlin · Germany Contact
Dr. Christine Lang · CEO Phone +49 30 46307200 Fax +49 30 46307210 info@organobalance.com www.organobalance.com Contact us: Phone: +49 (0)30 / 2125-4747 E-mail: wachsen@ibb.de www.ibb.de/wachsen Our tailored fi nancing are your key to success. Our consultants look forward to meeting you. Getting your innovation going. 140305_IBBanz_biotop12_210x148.indd 1 05.03.14 12:22
31 BioTOPics 47 | May 2014 BioTOP-Report 2014 syneed medidata GmbH Are you getting the whole picture? We Do.
syneed medidata GmbH is an independent, privately owned contract research organiza- tion (CRO) providing end-to-end services for phase I to phase IV clinical trials and for non- interventional studies. Commencing busi- ness in 1985, we have constantly expanded our service portfolio. In 1995 we conducted our first medical device study, and in the same year we started our Imaging Core Lab operations (see below). Moreover, we offer the complete scope of Pharmacovigilance services for development projects as well as for marketed products (drugs and medical devices). Our notion of service is based on the knowledge that every project is unique – and that custom-tailored solutions serve best. This is reflected in all our actions. As an example, for data capture our clients may choose between paper and different EDC solutions, including our proprietary EDC sys- tem, which has been developed for multina- tional non-interventional studies and gets enthusiastic feedback from both customers and end-users. syneed medidata GmbH combines experience with the quality, dedi- cation and flexibility of a midsized organiza- tion. So, for almost any trial you can think of, we provide the expertise you need for turning data into results. Address syneed medidata GmbH Cicerostraße 21 10709 Berlin · Germany Phone +49 30 31172751 00 www.medidata.de info@medidata.de Contact
Dr. Christian Hucke Clinical Program Director christian.hucke@medidata.de syneed imaging syneed imaging, the Medical Imaging Core Lab of syneed medidata GmbH, offers solu- tions for study planning, protocol develop- ment, site evaluation, image collection and processing and conduct of central indepen- dent reviews with a wide variety of criteria (e.g. RECIST, 1.0 and 1.1, Choi, Cheson, irRC, RANO, PERCIST, mRECIST). Within almost 20 years of operation we have managed trials in various indications (oncol- ogy, neurology, radiology, PET diagnostics, devices) and modalities, and established an extensive network of medical experts who support us as consultants and independent readers. Our experience, flexibility and pric- ing especially for early phase trials are highly valued by Biotech clients. All study data are hosted solely in Germany on our servers maintained by own IT staff. Address
syneed imaging & syneed medidata GmbH Cicerostraße 21 10709 Berlin · Germany Phone +49 30 31172751 00
Contact
John Uiters Director Medical Imaging Services john.uiters@medidata.de Full clinical and biometric services for clinical trials and non-interventional studies
Operational services offered in EU, CEE, Russia and USA through our established alliance of partner CROs Very high staff retention - stable, experienced teams delivering projects on time and with highest quality Pharmacovigilance and Imaging services for development projects and marketed products tailor-made services
Our tailored fi nancing are your key to success. Our consultants look forward to meeting you. Getting your innovation going. 140305_IBBanz_biotop12_210x148.indd 1 05.03.14 12:22
Yüklə 0,7 Mb. Dostları ilə paylaş:
|